Hepatic steatosis and fibrosis: Non-invasive assessment.
about
Impact of Virtual Touch Quantification in Acoustic Radiation Force Impulse for Skeletal Muscle Mass Loss in Chronic Liver DiseasesThe ASK1 Inhibitor Selonsertib in Patients with Nonalcoholic Steatohepatitis: A Randomized, Phase 2 Trial.Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.Fatty liver index, albuminuria and the association with chronic kidney disease: a population-based study in China.
P2860
Hepatic steatosis and fibrosis: Non-invasive assessment.
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Hepatic steatosis and fibrosis: Non-invasive assessment
@nl
Hepatic steatosis and fibrosis: Non-invasive assessment.
@ast
Hepatic steatosis and fibrosis: Non-invasive assessment.
@en
type
label
Hepatic steatosis and fibrosis: Non-invasive assessment
@nl
Hepatic steatosis and fibrosis: Non-invasive assessment.
@ast
Hepatic steatosis and fibrosis: Non-invasive assessment.
@en
prefLabel
Hepatic steatosis and fibrosis: Non-invasive assessment
@nl
Hepatic steatosis and fibrosis: Non-invasive assessment.
@ast
Hepatic steatosis and fibrosis: Non-invasive assessment.
@en
P2093
P2860
P921
P356
P1476
Hepatic steatosis and fibrosis: Non-invasive assessment
@en
P2093
Haddy K S Fye
Mary M E Crossey
Ramou Njie
Robert D Goldin
Rustam N Karanjia
Simon D Taylor-Robinson
P2860
P304
P356
10.3748/WJG.V22.I45.9880
P407
P50
P5008
P577
2016-12-01T00:00:00Z